• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  • Anti-malaria medications: warnings, research and withdrawn permissions for use

    United States // Canada // 15 June, 2020

    Use of the anti-malarial drug hydroxychloroquine as a treatment for COVID-19 continues to divide experts...

    COVID-19, General Articles

  • Pretreating household materials with salt-based solutions can provide effective filtration

    15 June, 2020

    Increasing the lifespan of surgical and N95 masks by adding an extra layer, pretreated with NaCl...

    COVID-19

  • Face masks in public "the most effective means" to reduce transmission of COVID-19

    13 June, 2020

    The use of masks by the general public has had an effect in slowing transmision of COVID-19. ..

    COVID-19

  • WHO: breastfeeding encouraged regardless of parent's COVID-19 status

    12 June, 2020

    Based on available evidence, the WHO recommends...

    COVID-19, General Articles

  • Levilimab approved in Russia for treating severe COVID-19

    Russia // 12 June, 2020

    Russia has approved Levilimab for treating severe COVID-19 disease...

    COVID-19

  • ECDC Tenth Risk Assessment for COVID-19 in Europe and UK

    12 June, 2020

    The ECDC has published the tenth risk assessment for the COVID-19 in the EU/EEA countries and the UK, with overall decreasing trends noted...

    COVID-19

  • What is a "superspreader"?

    11 June, 2020

    A "superspreader" refers to a person who transmits an infection to many others....

    COVID-19, General Articles

  • Antibody Cocktail in Clinical Trials

    United States // 11 June, 2020

    REGN-COV2 antibody cocktail has entered clinical trials...

    COVID-19

  • Care before, during and after pregnancy - COVID-19

    11 June, 2020

    According to a publication (Caring for Women Who Are Planning a Pregnancy, Pregnant, or Postpartum During the COVID-19 Pandemic) in the Journal of the American Medical Association “much remains to be learned about its effects on pregnant women and newborns”.

    COVID-19

  • First Monoclonal Antibody Treatment Begins Clinical Trials

    Singapore // 11 June, 2020

    Phase 1 trial begins for first monoclonal antibody treatment...

    COVID-19

  • First Batch of Avifavir Delivered to Hospitals

    Russia // 11 June, 2020

    Batches of Avifavir on their way to patients...

    COVID-19

  • Phase Three Trial of mRNA-1273 Vaccine to Begin in July

    11 June, 2020

    Trial to evaluate efficacy of potential vaccine...

    COVID-19

  • Remdesivir offers protection against COVID-19 in monkeys

    11 June, 2020

    The antiviral drug remdesivir was found to be beneficial for treating macaque monkeys with COVID-19...

    COVID-19

  • Risk factors for severe COVID-19 disease

    South Korea // 11 June, 2020

    Risk factors associated with severe COVID-19 disease: diabetes, high body temperature...

    COVID-19

  • Study of COVID-19 clusters in Japan

    Japan // 11 June, 2020

    A study of community clusters in Japan identified over 60 clusters...

    COVID-19

  • Human Vaccine Trials Accelerating in the United States

    United States // 10 June, 2020

    Vaccine trials accelerating in the United States...

    COVID-19

  • More evidence that social distancing and face coverings reduce the risk of infection from COVID-19

    United States // 10 June, 2020

    Analysis of COVID-19 outbreak on the USS Theodore Roosevelt in March...

    COVID-19

  • Can COVID-19 be transmitted by people who do not have symptoms?

    10 June, 2020

    People who are infected can spread the disease for about two days before they have developed symptoms ....

    COVID-19

  • Modelling studies show over half a billion COVID-19 cases averted by NPIs

    09 June, 2020

    Two modelling studies have predicted the number of COVID-19 cases averted by various non-pharmaceutical interventions (NPIs) used...

    COVID-19, General Articles

  • WHO updates mask recommendations, says general public should wear facemasks

    05 June, 2020

    For the first time in this pandemic, WHO said...

    COVID-19, General Articles

  1. …
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS